Pramiracetam (N-[2-(Diisopropylamino)ethyl]-2-oxo-1-pyrrolidineacetamide) is a lipophilic racetam derivative known for its high bioavailability and affinity for choline transport modulation. It exhibits a higher potency compared to other racetams due to its hydrophobic structure, which facilitates efficient blood-brain barrier permeability in research models. This compound interacts with cholinergic and glutamatergic pathways, influencing high-affinity choline uptake (HACU) and AMPA receptor activity. Pramiracetam undergoes hepatic metabolism through deamination and hydroxylation, with primary excretion via renal pathways.
EXP:12.2027
Internet Explorer tarayıcısının 9.0 ve daha eski sürümlerini desteklememekteyiz. Web sitemizi doğru görüntüleyebilmek için tarayıcınızı güncelleyebilirsiniz, güncelleyemiyorsanız başka bir tarayıcıyı ücretsiz yükleyebilirsiniz.